本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。

Skip to main content

About ASKA Pharmaceutical Holdings

For Our Shareholders and Investors

1

NEWS RELEASES

ALL
NEWS
PRODUCTS
IR

September 24 2024
TechDoctor and ASKA Pharmaceutical Launch Joint Research on Dysmenorrhea in Cooperation with Healthcare App "4MOON"211.86 KB
August 23 2024
Personnel Change of ASKA Pharmaceutical205.29 KB
August 23 2024
ASKA Pharmaceutical Holdings Announces Personnel Change121.10 KB
August 16 2024
ASKA Pharmaceutical licensee Hyundai Receives Manufacturing and Marketing Approval in Republic of Korea for Oral Contraceptive Drospirenone158.53 KB
August 15 2024
Notice Concerning Completion of Payment for Disposal of Treasury Shares as Remuneration for Restricted Shares120.65 KB

Information published by ASKA Pharmaceutical Co., Ltd until March 31, 2021

IR E-mail Newsletter Service

Receive our latest IR information by e-mail.

Subscribe to the Service

ASKA Pharmaceutical Holdings Group

ASKA Pharmaceutical Holdings Group

For Our Shareholders and Investors

About ASKA Pharmaceutical Holdings